S
PRCT icon

SignatureFD’s Procept Biorobotics PRCT Stock Holding History

SignatureFD’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.3K Buy
723
+140
+24% +$3.5K ﹤0.01% 2435
2026
Q1 		$14.6K Sell
583
-753
-56% -$21.2K ﹤0.01% 2348
2025
Q4 		$42K Buy
1,336
+258
+24% +$8.56K ﹤0.01% 1750
2025
Q3 		$38.5K Buy
1,078
+694
+181% +$31.7K ﹤0.01% 1782
2025
Q2 		$22.1K Sell
384
-176
-31% -$9.95K ﹤0.01% 2001
2025
Q1 		$32.6K Sell
560
-129
-19% -$8.81K ﹤0.01% 1802
2024
Q4 		$55.5K Buy
689
+145
+27% +$12.4K ﹤0.01% 1532
2024
Q3 		$43.6K Buy
544
+99
+22% +$7.03K ﹤0.01% 1649
2024
Q2 		$27.2K Buy
445
+42
+10% +$2.5K ﹤0.01% 1817
2024
Q1 		$19.9K Hold
403
– – ﹤0.01% 1999
2023
Q4 		$16.9K Buy
+403
New +$13.7K ﹤0.01% 2002
2023
Q3 		– Sell
-54
Closed -$1.91K – 3281
2023
Q2 		$1.91K Buy
+54
New +$1.78K ﹤0.01% 2818
2023
Q1 		– Sell
-29
Closed -$1.21K – 3355
2022
Q4 		$1.21K Buy
+29
New +$1.25K ﹤0.01% 2934

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

SignatureFD's PRCT Position: Q2 2026 in Review

SignatureFD increased its Procept Biorobotics (PRCT) stake by 24% in Q2 2026, buying an estimated $3.5K and bringing the position to 723 shares worth $16.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2435.

SignatureFD first reported a position in PRCT in Q4 2022 and has held it in 13 quarters since. The position peaked at $55.5K in Q4 2024. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • SignatureFD held 723 shares of Procept Biorobotics worth $16.3K as of Q2 2026.
  • SignatureFD bought 140 Procept Biorobotics shares in Q2 2026, an estimated $3.5K.
  • Procept Biorobotics made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #2435 holding.
  • SignatureFD first reported a position in Procept Biorobotics in Q4 2022 and has held it in 13 quarters since.
  • SignatureFD's Procept Biorobotics position peaked at $55.5K in Q4 2024.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.